Industry

Interview
Laurel Oldach
Nov. 12, 2021
After his father had a stroke, Manjunath Goolyam Basavaraj decided to study blood clotting — research with a personal connection.
Read More

More in Industry

A turbulent industry: 5 questions with Paul Wright
Interview

A turbulent industry: 5 questions with Paul Wright

Sept. 10, 2021

Paul Wright, a chemist whose 28-year career in the pharmaceutical industry spanned many types of roles and companies, shares what he learned along the way with ASBMB Today.

“Very, very luckily for me, this project is going well.”
Jobs

“Very, very luckily for me, this project is going well.”

Aug. 13, 2021

Glycobiologist Vijayakanth Pagadala wasn’t looking for a career in biotechnology, but he’s glad to have found one.

What we’ve learned about careers in industry
Jobs

What we’ve learned about careers in industry

Aug. 6, 2021

Industry careers columnist Courtney Chandler and staff writer Laurel Oldach team up to offer advice for job seekers.

Biotech industry jargon: A primer for the curious
Professional Development

Biotech industry jargon: A primer for the curious

July 29, 2021

The specific scientific and technical knowledge you need in an industry job depends on the role and will change over the course of your career. But it can help to know the basics.

A primer on performance reviews in industry
Jobs

A primer on performance reviews in industry

July 16, 2021

Our industry careers columnist provides an overview of what you can expect and how to handle a lukewarm or negative review.

Why is the FDA funded in part by the companies it regulates?
Funding

Why is the FDA funded in part by the companies it regulates?

July 4, 2021

The U.S. Food and Drug Administration receives almost half its funding from companies it regulates, such as drug and medical device makers. Is this something you should be concerned about?

Essay

Biotechnology greed is prolonging the pandemic. It’s inexcusable.

In the debate over vaccine patents, a flawed logic is being used to justify putting profits above saving lives.
Biotechnology greed is prolonging the pandemic. It’s inexcusable.

More in Industry

Out for blood in the search to stall aging
Feature

Out for blood in the search to stall aging

July 3, 2021

A gaggle of biotech startups are trying vastly different approaches to spin animal studies into the next big anti-aging therapy. It’s too early to know which, if any, will succeed.

Climbing the research ladder in industry
Jobs

Climbing the research ladder in industry

June 25, 2021

Our industry careers columnist offers brief descriptions of entry-level, mid-level and senior-level positions in the R&D world.

Targeting 20,000 proteins by 2035
Feature

Targeting 20,000 proteins by 2035

May 26, 2021

The organizers of Target 2035, the Structural Genome Consortium, have an ambitious aim: to invent an inhibitor or probe for every protein in the human proteome by 2035. How will they do it?

‘I could be happy doing other things’
Interview

‘I could be happy doing other things’

May 19, 2021

Forensic investigations, IVF embryology, custom virus production for research: Alanna Mitsopoulos has done it all. In a Q&A with ASBMB Today, she describes her career path so far.

Working on sustainable science in industry
Jobs

Working on sustainable science in industry

May 14, 2021

Our industry careers columnist talked to Jake Courtney of Conagen, a biotechnology company that focuses on synthetic biology, about his role as a scientist in industry.

‘Grad school is just the foundation’
Interview

‘Grad school is just the foundation’

March 30, 2021

Rebecca Krisher, global director of reproductive biology at Genus, went from developing new techniques for human in vitro fertilization to research in animal breeding.

Join the ASBMB Today mailing list

Sign up to get updates on articles, interviews and events.